JP4119480B2 - 爪の成長促進剤 - Google Patents

爪の成長促進剤 Download PDF

Info

Publication number: JP4119480B2
Authority: JP; Japan
Prior art keywords: nail; nail varnish; varnish according; compound; action
Prior art date: 1996-02-06
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Expired - Lifetime

Application number

JP52809597A

Other languages

English (en)

Japanese (ja)

Other versions

JP2000504674A (ja

JP2000504674A5 (2

Inventor

ボーン，マンフレート

クレーマー，カール・テーオドーア

ウルブリヒト，ホルスト

Original Assignee

サノフィーアベンティス・ドイチュラント・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1996-02-06

Filing date

1997-01-23

Publication date

2008-07-16

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=7784609&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=JP4119480(B2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1997-01-23 Application filed by サノフィーアベンティス・ドイチュラント・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング filed Critical サノフィーアベンティス・ドイチュラント・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング

2000-04-18 Publication of JP2000504674A publication Critical patent/JP2000504674A/ja

2004-11-11 Publication of JP2000504674A5 publication Critical patent/JP2000504674A5/ja

2008-07-16 Application granted granted Critical

2008-07-16 Publication of JP4119480B2 publication Critical patent/JP4119480B2/ja

2017-01-23 Anticipated expiration legal-status Critical

Status Expired - Lifetime legal-status Critical Current

Links

230000036562 nail growth Effects 0.000 title description 11
239000007952 growth promoter Substances 0.000 title 1
239000002966 varnish Substances 0.000 claims abstract description 38
150000001875 compounds Chemical class 0.000 claims abstract description 30
239000003795 chemical substances by application Substances 0.000 claims abstract description 12
230000000304 vasodilatating effect Effects 0.000 claims abstract description 5
229940121375 antifungal agent Drugs 0.000 claims description 17
239000003429 antifungal agent Substances 0.000 claims description 16
-1 allyl compound Chemical class 0.000 claims description 11
229920001577 copolymer Polymers 0.000 claims description 11
230000009471 action Effects 0.000 claims description 10
ZIMGGGWCDYVHOY-UHFFFAOYSA-N 3-hydroxy-2-imino-6-(1-piperidinyl)-4-pyrimidinamine Chemical compound N=C1N(O)C(N)=CC(N2CCCCC2)=N1 ZIMGGGWCDYVHOY-UHFFFAOYSA-N 0.000 claims description 4
JIGUQPWFLRLWPJ-UHFFFAOYSA-N Ethyl acrylate Chemical compound CCOC(=O)C=C JIGUQPWFLRLWPJ-UHFFFAOYSA-N 0.000 claims description 4
BYBLEWFAAKGYCD-UHFFFAOYSA-N Miconazole Chemical compound ClC1=CC(Cl)=CC=C1COC(C=1C(=CC(Cl)=CC=1)Cl)CN1C=NC=C1 BYBLEWFAAKGYCD-UHFFFAOYSA-N 0.000 claims description 4
239000000020 Nitrocellulose Substances 0.000 claims description 4
FJWGYAHXMCUOOM-QHOUIDNNSA-N [(2s,3r,4s,5r,6r)-2-[(2r,3r,4s,5r,6s)-4,5-dinitrooxy-2-(nitrooxymethyl)-6-[(2r,3r,4s,5r,6s)-4,5,6-trinitrooxy-2-(nitrooxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-3,5-dinitrooxy-6-(nitrooxymethyl)oxan-4-yl] nitrate Chemical compound O([C@@H]1O[C@@H]([C@H]([C@H](O[N+]([O-])=O)[C@H]1O[N+]([O-])=O)O[C@H]1[C@@H]([C@@H](O[N+]([O-])=O)[C@H](O[N+]([O-])=O)[C@@H](CO[N+]([O-])=O)O1)O[N+]([O-])=O)CO[N+](=O)[O-])[C@@H]1[C@@H](CO[N+]([O-])=O)O[C@@H](O[N+]([O-])=O)[C@H](O[N+]([O-])=O)[C@H]1O[N+]([O-])=O FJWGYAHXMCUOOM-QHOUIDNNSA-N 0.000 claims description 4
229920001220 nitrocellulos Polymers 0.000 claims description 4
PNJWIWWMYCMZRO-UHFFFAOYSA-N pent‐4‐en‐2‐one Natural products CC(=O)CC=C PNJWIWWMYCMZRO-UHFFFAOYSA-N 0.000 claims description 4
VVQNEPGJFQJSBK-UHFFFAOYSA-N Methyl methacrylate Chemical compound COC(=O)C(C)=C VVQNEPGJFQJSBK-UHFFFAOYSA-N 0.000 claims description 3
XJRBAMWJDBPFIM-UHFFFAOYSA-N methyl vinyl ether Chemical compound COC=C XJRBAMWJDBPFIM-UHFFFAOYSA-N 0.000 claims description 3
229960002509 miconazole Drugs 0.000 claims description 3
229920002037 poly(vinyl butyral) polymer Polymers 0.000 claims description 3
229960002722 terbinafine Drugs 0.000 claims description 3
DOMXUEMWDBAQBQ-WEVVVXLNSA-N terbinafine Chemical compound C1=CC=C2C(CN(C\C=C\C#CC(C)(C)C)C)=CC=CC2=C1 DOMXUEMWDBAQBQ-WEVVVXLNSA-N 0.000 claims description 3
XMAYWYJOQHXEEK-OZXSUGGESA-N (2R,4S)-ketoconazole Chemical compound C1CN(C(=O)C)CCN1C(C=C1)=CC=C1OC[C@@H]1O[C@@](CN2C=NC=C2)(C=2C(=CC(Cl)=CC=2)Cl)OC1 XMAYWYJOQHXEEK-OZXSUGGESA-N 0.000 claims description 2
MPIPASJGOJYODL-SFHVURJKSA-N (R)-isoconazole Chemical compound ClC1=CC(Cl)=CC=C1[C@@H](OCC=1C(=CC=CC=1Cl)Cl)CN1C=NC=C1 MPIPASJGOJYODL-SFHVURJKSA-N 0.000 claims description 2
OCAPBUJLXMYKEJ-UHFFFAOYSA-N 1-[biphenyl-4-yl(phenyl)methyl]imidazole Chemical compound C1=NC=CN1C(C=1C=CC(=CC=1)C=1C=CC=CC=1)C1=CC=CC=C1 OCAPBUJLXMYKEJ-UHFFFAOYSA-N 0.000 claims description 2
LEZWWPYKPKIXLL-UHFFFAOYSA-N 1-{2-(4-chlorobenzyloxy)-2-(2,4-dichlorophenyl)ethyl}imidazole Chemical compound C1=CC(Cl)=CC=C1COC(C=1C(=CC(Cl)=CC=1)Cl)CN1C=NC=C1 LEZWWPYKPKIXLL-UHFFFAOYSA-N 0.000 claims description 2
WHPAGCJNPTUGGD-UHFFFAOYSA-N Croconazole Chemical compound ClC1=CC=CC(COC=2C(=CC=CC=2)C(=C)N2C=NC=C2)=C1 WHPAGCJNPTUGGD-UHFFFAOYSA-N 0.000 claims description 2
IIUZTXTZRGLYTI-UHFFFAOYSA-N Dihydrogriseofulvin Natural products COC1CC(=O)CC(C)C11C(=O)C(C(OC)=CC(OC)=C2Cl)=C2O1 IIUZTXTZRGLYTI-UHFFFAOYSA-N 0.000 claims description 2
UXWOXTQWVMFRSE-UHFFFAOYSA-N Griseoviridin Natural products O=C1OC(C)CC=C(C(NCC=CC=CC(O)CC(O)C2)=O)SCC1NC(=O)C1=COC2=N1 UXWOXTQWVMFRSE-UHFFFAOYSA-N 0.000 claims description 2
DDUHZTYCFQRHIY-UHFFFAOYSA-N Negwer: 6874 Natural products COC1=CC(=O)CC(C)C11C(=O)C(C(OC)=CC(OC)=C2Cl)=C2O1 DDUHZTYCFQRHIY-UHFFFAOYSA-N 0.000 claims description 2
229960002206 bifonazole Drugs 0.000 claims description 2
229960002962 butenafine Drugs 0.000 claims description 2
ABJKWBDEJIDSJZ-UHFFFAOYSA-N butenafine Chemical compound C=1C=CC2=CC=CC=C2C=1CN(C)CC1=CC=C(C(C)(C)C)C=C1 ABJKWBDEJIDSJZ-UHFFFAOYSA-N 0.000 claims description 2
229960004022 clotrimazole Drugs 0.000 claims description 2
VNFPBHJOKIVQEB-UHFFFAOYSA-N clotrimazole Chemical compound ClC1=CC=CC=C1C(N1C=NC=C1)(C=1C=CC=CC=1)C1=CC=CC=C1 VNFPBHJOKIVQEB-UHFFFAOYSA-N 0.000 claims description 2
229960002042 croconazole Drugs 0.000 claims description 2
229960003913 econazole Drugs 0.000 claims description 2
DDUHZTYCFQRHIY-RBHXEPJQSA-N griseofulvin Chemical compound COC1=CC(=O)C[C@@H](C)[C@@]11C(=O)C(C(OC)=CC(OC)=C2Cl)=C2O1 DDUHZTYCFQRHIY-RBHXEPJQSA-N 0.000 claims description 2
229960002867 griseofulvin Drugs 0.000 claims description 2
229960004849 isoconazole Drugs 0.000 claims description 2
229960004125 ketoconazole Drugs 0.000 claims description 2
229920003145 methacrylic acid copolymer Polymers 0.000 claims description 2
150000002780 morpholines Chemical class 0.000 claims description 2
229960003483 oxiconazole Drugs 0.000 claims description 2
QRJJEGAJXVEBNE-MOHJPFBDSA-N oxiconazole Chemical compound ClC1=CC(Cl)=CC=C1CO\N=C(C=1C(=CC(Cl)=CC=1)Cl)\CN1C=NC=C1 QRJJEGAJXVEBNE-MOHJPFBDSA-N 0.000 claims description 2
OIQJEQLSYJSNDS-UHFFFAOYSA-N piroctone Chemical compound CC(C)(C)CC(C)CC1=CC(C)=CC(=O)N1O OIQJEQLSYJSNDS-UHFFFAOYSA-N 0.000 claims description 2
229950001046 piroctone Drugs 0.000 claims description 2
229960004880 tolnaftate Drugs 0.000 claims description 2
FUSNMLFNXJSCDI-UHFFFAOYSA-N tolnaftate Chemical compound C=1C=C2C=CC=CC2=CC=1OC(=S)N(C)C1=CC=CC(C)=C1 FUSNMLFNXJSCDI-UHFFFAOYSA-N 0.000 claims description 2
KAESVJOAVNADME-UHFFFAOYSA-N Pyrrole Chemical compound C=1C=CNC=1 KAESVJOAVNADME-UHFFFAOYSA-N 0.000 claims 2
UDYUIWXQUBNDHC-UHFFFAOYSA-N 6-[[4-(4-chlorophenoxy)phenoxy]methyl]-1-hydroxy-4-methylpyridin-2-one Chemical compound ON1C(=O)C=C(C)C=C1COC(C=C1)=CC=C1OC1=CC=C(Cl)C=C1 UDYUIWXQUBNDHC-UHFFFAOYSA-N 0.000 claims 1
238000004581 coalescence Methods 0.000 claims 1
229950006862 rilopirox Drugs 0.000 claims 1
238000011282 treatment Methods 0.000 abstract description 25
230000009548 growth disturbance Effects 0.000 abstract 1
210000000282 nail Anatomy 0.000 description 81
239000000203 mixture Substances 0.000 description 30
238000009472 formulation Methods 0.000 description 22
XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 15
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 14
239000002904 solvent Substances 0.000 description 11
208000010195 Onychomycosis Diseases 0.000 description 9
239000000126 substance Substances 0.000 description 9
238000012360 testing method Methods 0.000 description 9
201000005882 tinea unguium Diseases 0.000 description 9
210000004905 finger nail Anatomy 0.000 description 8
238000009835 boiling Methods 0.000 description 6
210000004904 fingernail bed Anatomy 0.000 description 6
125000004435 hydrogen atom Chemical group [H]* 0.000 description 6
238000012545 processing Methods 0.000 description 6
210000004906 toe nail Anatomy 0.000 description 6
150000002148 esters Chemical class 0.000 description 5
239000011159 matrix material Substances 0.000 description 5
SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 description 4
NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 4
KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 4
241001272720 Medialuna californiensis Species 0.000 description 4
238000001035 drying Methods 0.000 description 4
208000037824 growth disorder Diseases 0.000 description 4
208000015181 infectious disease Diseases 0.000 description 4
210000003491 skin Anatomy 0.000 description 4
230000009885 systemic effect Effects 0.000 description 4
241000283690 Bos taurus Species 0.000 description 3
241000233866 Fungi Species 0.000 description 3
CERQOIWHTDAKMF-UHFFFAOYSA-N Methacrylic acid Chemical compound CC(=C)C(O)=O CERQOIWHTDAKMF-UHFFFAOYSA-N 0.000 description 3
YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
239000000654 additive Substances 0.000 description 3
150000001298 alcohols Chemical class 0.000 description 3
235000015278 beef Nutrition 0.000 description 3
125000004432 carbon atom Chemical group C* 0.000 description 3
SCKYRAXSEDYPSA-UHFFFAOYSA-N ciclopirox Chemical compound ON1C(=O)C=C(C)C=C1C1CCCCC1 SCKYRAXSEDYPSA-UHFFFAOYSA-N 0.000 description 3
230000000052 comparative effect Effects 0.000 description 3
239000002537 cosmetic Substances 0.000 description 3
LDHQCZJRKDOVOX-NSCUHMNNSA-N crotonic acid Chemical compound C\C=C\C(O)=O LDHQCZJRKDOVOX-NSCUHMNNSA-N 0.000 description 3
UAOMVDZJSHZZME-UHFFFAOYSA-N diisopropylamine Chemical compound CC(C)NC(C)C UAOMVDZJSHZZME-UHFFFAOYSA-N 0.000 description 3
201000010099 disease Diseases 0.000 description 3
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
230000006870 function Effects 0.000 description 3
239000000463 material Substances 0.000 description 3
238000000034 method Methods 0.000 description 3
244000005700 microbiome Species 0.000 description 3
125000004433 nitrogen atom Chemical group N* 0.000 description 3
125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 3
229920000642 polymer Polymers 0.000 description 3
150000003839 salts Chemical class 0.000 description 3
LDHQCZJRKDOVOX-UHFFFAOYSA-N trans-crotonic acid Natural products CC=CC(O)=O LDHQCZJRKDOVOX-UHFFFAOYSA-N 0.000 description 3
229940124549 vasodilator Drugs 0.000 description 3
239000003071 vasodilator agent Substances 0.000 description 3
125000006552 (C3-C8) cycloalkyl group Chemical group 0.000 description 2
125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 description 2
239000005541 ACE inhibitor Substances 0.000 description 2
OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 2
JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 2
XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical class NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
XTXRWKRVRITETP-UHFFFAOYSA-N Vinyl acetate Chemical compound CC(=O)OC=C XTXRWKRVRITETP-UHFFFAOYSA-N 0.000 description 2
DOQPXTMNIUCOSY-UHFFFAOYSA-N [4-cyano-4-(3,4-dimethoxyphenyl)-5-methylhexyl]-[2-(3,4-dimethoxyphenyl)ethyl]-methylazanium;chloride Chemical compound [H+].[Cl-].C1=C(OC)C(OC)=CC=C1CCN(C)CCCC(C#N)(C(C)C)C1=CC=C(OC)C(OC)=C1 DOQPXTMNIUCOSY-UHFFFAOYSA-N 0.000 description 2
125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 description 2
125000000217 alkyl group Chemical group 0.000 description 2
POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical class NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 description 2
229940044094 angiotensin-converting-enzyme inhibitor Drugs 0.000 description 2
230000000844 anti-bacterial effect Effects 0.000 description 2
230000008901 benefit Effects 0.000 description 2
230000008859 change Effects 0.000 description 2
230000004087 circulation Effects 0.000 description 2
239000013078 crystal Substances 0.000 description 2
230000006378 damage Effects 0.000 description 2
DOIRQSBPFJWKBE-UHFFFAOYSA-N dibutyl phthalate Chemical compound CCCCOC(=O)C1=CC=CC=C1C(=O)OCCCC DOIRQSBPFJWKBE-UHFFFAOYSA-N 0.000 description 2
238000002845 discoloration Methods 0.000 description 2
239000003814 drug Substances 0.000 description 2
230000000694 effects Effects 0.000 description 2
210000002615 epidermis Anatomy 0.000 description 2
125000000623 heterocyclic group Chemical group 0.000 description 2
229930195733 hydrocarbon Natural products 0.000 description 2
150000002430 hydrocarbons Chemical class 0.000 description 2
VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 2
239000011976 maleic acid Substances 0.000 description 2
238000004519 manufacturing process Methods 0.000 description 2
238000005259 measurement Methods 0.000 description 2
210000000056 organ Anatomy 0.000 description 2
230000035515 penetration Effects 0.000 description 2
239000000049 pigment Substances 0.000 description 2
239000004014 plasticizer Substances 0.000 description 2
229920002689 polyvinyl acetate Polymers 0.000 description 2
239000011118 polyvinyl acetate Substances 0.000 description 2
230000008569 process Effects 0.000 description 2
GGOZGYRTNQBSSA-UHFFFAOYSA-N pyridine-2,3-diol Chemical class OC1=CC=CN=C1O GGOZGYRTNQBSSA-UHFFFAOYSA-N 0.000 description 2
WRHZVMBBRYBTKZ-UHFFFAOYSA-N pyrrole-2-carboxylic acid Chemical compound OC(=O)C1=CC=CN1 WRHZVMBBRYBTKZ-UHFFFAOYSA-N 0.000 description 2
229960003401 ramipril Drugs 0.000 description 2
HDACQVRGBOVJII-JBDAPHQKSA-N ramipril Chemical compound C([C@@H](C(=O)OCC)N[C@@H](C)C(=O)N1[C@@H](C[C@@H]2CCC[C@@H]21)C(O)=O)CC1=CC=CC=C1 HDACQVRGBOVJII-JBDAPHQKSA-N 0.000 description 2
YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical class OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
210000000434 stratum corneum Anatomy 0.000 description 2
CWERGRDVMFNCDR-UHFFFAOYSA-N thioglycolic acid Chemical class OC(=O)CS CWERGRDVMFNCDR-UHFFFAOYSA-N 0.000 description 2
210000001519 tissue Anatomy 0.000 description 2
VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 2
URAYPUMNDPQOKB-UHFFFAOYSA-N triacetin Chemical compound CC(=O)OCC(OC(C)=O)COC(C)=O URAYPUMNDPQOKB-UHFFFAOYSA-N 0.000 description 2
JWZZKOKVBUJMES-UHFFFAOYSA-N (+-)-Isoprenaline Chemical compound CC(C)NCC(O)C1=CC=C(O)C(O)=C1 JWZZKOKVBUJMES-UHFFFAOYSA-N 0.000 description 1
HMJIYCCIJYRONP-UHFFFAOYSA-N (+-)-Isradipine Chemical compound COC(=O)C1=C(C)NC(C)=C(C(=O)OC(C)C)C1C1=CC=CC2=NON=C12 HMJIYCCIJYRONP-UHFFFAOYSA-N 0.000 description 1
BIDNLKIUORFRQP-XYGFDPSESA-N (2s,4s)-4-cyclohexyl-1-[2-[[(1s)-2-methyl-1-propanoyloxypropoxy]-(4-phenylbutyl)phosphoryl]acetyl]pyrrolidine-2-carboxylic acid Chemical compound C([P@@](=O)(O[C@H](OC(=O)CC)C(C)C)CC(=O)N1[C@@H](C[C@H](C1)C1CCCCC1)C(O)=O)CCCC1=CC=CC=C1 BIDNLKIUORFRQP-XYGFDPSESA-N 0.000 description 1
125000004169 (C1-C6) alkyl group Chemical group 0.000 description 1
DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical compound C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 description 1
PVHUJELLJLJGLN-INIZCTEOSA-N (S)-nitrendipine Chemical compound CCOC(=O)C1=C(C)NC(C)=C(C(=O)OC)[C@@H]1C1=CC=CC([N+]([O-])=O)=C1 PVHUJELLJLJGLN-INIZCTEOSA-N 0.000 description 1
VZXTWGWHSMCWGA-UHFFFAOYSA-N 1,3,5-triazine-2,4-diamine Chemical class NC1=NC=NC(N)=N1 VZXTWGWHSMCWGA-UHFFFAOYSA-N 0.000 description 1
JSYOKKNLZSPUCV-UHFFFAOYSA-N 1-hydroxy-4-methyl-6-(2,4,4-trimethylcyclohexa-1,5-dien-1-yl)pyridin-2-one Chemical compound C1=CC(C)(C)CC(C)=C1C1=CC(C)=CC(=O)N1O JSYOKKNLZSPUCV-UHFFFAOYSA-N 0.000 description 1
XZKWIPVTHGWDCF-UHFFFAOYSA-N 2,6-dimethyl-4-[2-methyl-3-[4-(2-methylbutan-2-yl)phenyl]propyl]morpholine;hydron;chloride Chemical compound Cl.C1=CC(C(C)(C)CC)=CC=C1CC(C)CN1CC(C)OC(C)C1 XZKWIPVTHGWDCF-UHFFFAOYSA-N 0.000 description 1
SGTNSNPWRIOYBX-UHFFFAOYSA-N 2-(3,4-dimethoxyphenyl)-5-{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino}-2-(propan-2-yl)pentanenitrile Chemical compound C1=C(OC)C(OC)=CC=C1CCN(C)CCCC(C#N)(C(C)C)C1=CC=C(OC)C(OC)=C1 SGTNSNPWRIOYBX-UHFFFAOYSA-N 0.000 description 1
NMKSAYKQLCHXDK-UHFFFAOYSA-N 3,3-diphenyl-N-(1-phenylethyl)-1-propanamine Chemical compound C=1C=CC=CC=1C(C)NCCC(C=1C=CC=CC=1)C1=CC=CC=C1 NMKSAYKQLCHXDK-UHFFFAOYSA-N 0.000 description 1
UIAGMCDKSXEBJQ-IBGZPJMESA-N 3-o-(2-methoxyethyl) 5-o-propan-2-yl (4s)-2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate Chemical compound COCCOC(=O)C1=C(C)NC(C)=C(C(=O)OC(C)C)[C@H]1C1=CC=CC([N+]([O-])=O)=C1 UIAGMCDKSXEBJQ-IBGZPJMESA-N 0.000 description 1
LBSRZVRITCRLIU-UHFFFAOYSA-N 3-o-ethyl 5-o-(2-piperidin-1-ylethyl) 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate Chemical compound CCOC(=O)C1=C(C)NC(C)=C(C(=O)OCCN2CCCCC2)C1C1=CC=CC([N+]([O-])=O)=C1 LBSRZVRITCRLIU-UHFFFAOYSA-N 0.000 description 1
125000004575 3-pyrrolidinyl group Chemical group [H]N1C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
RZTAMFZIAATZDJ-HNNXBMFYSA-N 5-o-ethyl 3-o-methyl (4s)-4-(2,3-dichlorophenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate Chemical compound CCOC(=O)C1=C(C)NC(C)=C(C(=O)OC)[C@@H]1C1=CC=CC(Cl)=C1Cl RZTAMFZIAATZDJ-HNNXBMFYSA-N 0.000 description 1
WBXDEEFCGDIKFC-UHFFFAOYSA-N 6-(3-bicyclo[2.2.1]heptanyl)-1-hydroxy-4-methylpyridin-2-one Chemical compound ON1C(=O)C=C(C)C=C1C1C(C2)CCC2C1 WBXDEEFCGDIKFC-UHFFFAOYSA-N 0.000 description 1
RTAPDZBZLSXHQQ-UHFFFAOYSA-N 8-methyl-3,7-dihydropurine-2,6-dione Chemical class N1C(=O)NC(=O)C2=C1N=C(C)N2 RTAPDZBZLSXHQQ-UHFFFAOYSA-N 0.000 description 1
POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Chemical class NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 description 1
101710129690 Angiotensin-converting enzyme inhibitor Proteins 0.000 description 1
101710086378 Bradykinin-potentiating and C-type natriuretic peptides Proteins 0.000 description 1
DKPFZGUDAPQIHT-UHFFFAOYSA-N Butyl acetate Natural products CCCCOC(C)=O DKPFZGUDAPQIHT-UHFFFAOYSA-N 0.000 description 1
YKRDKMNLBVQSOH-UHFFFAOYSA-N CCCCOC1=NC(N)=[N+]([O-])C(N)=N1 Chemical compound CCCCOC1=NC(N)=[N+]([O-])C(N)=N1 YKRDKMNLBVQSOH-UHFFFAOYSA-N 0.000 description 1
229940127291 Calcium channel antagonist Drugs 0.000 description 1
241000723346 Cinnamomum camphora Species 0.000 description 1
PQUCIEFHOVEZAU-UHFFFAOYSA-N Diammonium sulfite Chemical compound [NH4+].[NH4+].[O-]S([O-])=O PQUCIEFHOVEZAU-UHFFFAOYSA-N 0.000 description 1
108090000790 Enzymes Chemical class 0.000 description 1
102000004190 Enzymes Human genes 0.000 description 1
229920003134 Eudragit® polymer Polymers 0.000 description 1
238000005033 Fourier transform infrared spectroscopy Methods 0.000 description 1
238000001157 Fourier transform infrared spectrum Methods 0.000 description 1
206010017533 Fungal infection Diseases 0.000 description 1
102000011782 Keratins Human genes 0.000 description 1
108010076876 Keratins Proteins 0.000 description 1
229940124091 Keratolytic Drugs 0.000 description 1
239000004166 Lanolin Substances 0.000 description 1
108010007859 Lisinopril Proteins 0.000 description 1
WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 description 1
ZBBHBTPTTSWHBA-UHFFFAOYSA-N Nicardipine Chemical compound COC(=O)C1=C(C)NC(C)=C(C(=O)OCCN(C)CC=2C=CC=CC=2)C1C1=CC=CC([N+]([O-])=O)=C1 ZBBHBTPTTSWHBA-UHFFFAOYSA-N 0.000 description 1
FAIIFDPAEUKBEP-UHFFFAOYSA-N Nilvadipine Chemical compound COC(=O)C1=C(C#N)NC(C)=C(C(=O)OC(C)C)C1C1=CC=CC([N+]([O-])=O)=C1 FAIIFDPAEUKBEP-UHFFFAOYSA-N 0.000 description 1
BYPFEZZEUUWMEJ-UHFFFAOYSA-N Pentoxifylline Chemical compound O=C1N(CCCCC(=O)C)C(=O)N(C)C2=C1N(C)C=N2 BYPFEZZEUUWMEJ-UHFFFAOYSA-N 0.000 description 1
RBQOQRRFDPXAGN-UHFFFAOYSA-N Propentofylline Chemical compound CN1C(=O)N(CCCCC(C)=O)C(=O)C2=C1N=CN2CCC RBQOQRRFDPXAGN-UHFFFAOYSA-N 0.000 description 1
VXFJYXUZANRPDJ-WTNASJBWSA-N Trandopril Chemical compound C([C@@H](C(=O)OCC)N[C@@H](C)C(=O)N1[C@@H](C[C@H]2CCCC[C@@H]21)C(O)=O)CC1=CC=CC=C1 VXFJYXUZANRPDJ-WTNASJBWSA-N 0.000 description 1
241001045770 Trichophyton mentagrophytes Species 0.000 description 1
241000223229 Trichophyton rubrum Species 0.000 description 1
TYVWBCMQECJNSK-UHFFFAOYSA-N [2-methyl-3-(2-methylprop-2-enoyloxy)butan-2-yl]azanium;chloride Chemical compound [Cl-].CC([NH3+])(C)C(C)OC(=O)C(C)=C TYVWBCMQECJNSK-UHFFFAOYSA-N 0.000 description 1
MFAIKGYHWQMVDE-UHFFFAOYSA-N [OH-].NC1[NH+]=C(C=C(N1OS(=O)(=O)O)N)OCCCC Chemical class [OH-].NC1[NH+]=C(C=C(N1OS(=O)(=O)O)N)OCCCC MFAIKGYHWQMVDE-UHFFFAOYSA-N 0.000 description 1
DHKHKXVYLBGOIT-UHFFFAOYSA-N acetaldehyde Diethyl Acetal Natural products CCOC(C)OCC DHKHKXVYLBGOIT-UHFFFAOYSA-N 0.000 description 1
150000001241 acetals Chemical class 0.000 description 1
239000002253 acid Substances 0.000 description 1
150000007513 acids Chemical class 0.000 description 1
239000013543 active substance Substances 0.000 description 1
125000001980 alanyl group Chemical group 0.000 description 1
150000001336 alkenes Chemical class 0.000 description 1
125000003545 alkoxy group Chemical group 0.000 description 1
125000005250 alkyl acrylate group Chemical group 0.000 description 1
125000005907 alkyl ester group Chemical group 0.000 description 1
229960000458 allantoin Drugs 0.000 description 1
229960000528 amlodipine Drugs 0.000 description 1
HTIQEAQVCYTUBX-UHFFFAOYSA-N amlodipine Chemical compound CCOC(=O)C1=C(COCCN)NC(C)=C(C(=O)OC)C1C1=CC=CC=C1Cl HTIQEAQVCYTUBX-UHFFFAOYSA-N 0.000 description 1
QGZKDVFQNNGYKY-UHFFFAOYSA-O ammonium group Chemical group [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 1
230000000843 anti-fungal effect Effects 0.000 description 1
125000004069 aziridinyl group Chemical group 0.000 description 1
150000003851 azoles Chemical class 0.000 description 1
125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 1
230000015572 biosynthetic process Effects 0.000 description 1
238000009395 breeding Methods 0.000 description 1
230000001488 breeding effect Effects 0.000 description 1
UTOVMEACOLCUCK-PLNGDYQASA-N butyl maleate Chemical compound CCCCOC(=O)\C=C/C(O)=O UTOVMEACOLCUCK-PLNGDYQASA-N 0.000 description 1
229960000846 camphor Drugs 0.000 description 1
229930008380 camphor Natural products 0.000 description 1
229960000830 captopril Drugs 0.000 description 1
FAKRSMQSSFJEIM-RQJHMYQMSA-N captopril Chemical compound SC[C@@H](C)C(=O)N1CCC[C@H]1C(O)=O FAKRSMQSSFJEIM-RQJHMYQMSA-N 0.000 description 1
239000004202 carbamide Chemical class 0.000 description 1
230000001413 cellular effect Effects 0.000 description 1
239000007795 chemical reaction product Substances 0.000 description 1
210000004087 cornea Anatomy 0.000 description 1
125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 1
230000007423 decrease Effects 0.000 description 1
230000007812 deficiency Effects 0.000 description 1
230000001627 detrimental effect Effects 0.000 description 1
229960004042 diazoxide Drugs 0.000 description 1
230000037213 diet Effects 0.000 description 1
235000005911 diet Nutrition 0.000 description 1
235000014113 dietary fatty acids Nutrition 0.000 description 1
229940043279 diisopropylamine Drugs 0.000 description 1
229960004166 diltiazem Drugs 0.000 description 1
HSUGRBWQSSZJOP-RTWAWAEBSA-N diltiazem Chemical compound C1=CC(OC)=CC=C1[C@H]1[C@@H](OC(C)=O)C(=O)N(CCN(C)C)C2=CC=CC=C2S1 HSUGRBWQSSZJOP-RTWAWAEBSA-N 0.000 description 1
235000019329 dioctyl sodium sulphosuccinate Nutrition 0.000 description 1
YHAIUSTWZPMYGG-UHFFFAOYSA-L disodium;2,2-dioctyl-3-sulfobutanedioate Chemical compound [Na+].[Na+].CCCCCCCCC(C([O-])=O)(C(C([O-])=O)S(O)(=O)=O)CCCCCCCC YHAIUSTWZPMYGG-UHFFFAOYSA-L 0.000 description 1
229940079593 drug Drugs 0.000 description 1
239000000975 dye Substances 0.000 description 1
230000002500 effect on skin Effects 0.000 description 1
229940088598 enzyme Drugs 0.000 description 1
150000002168 ethanoic acid esters Chemical class 0.000 description 1
TVFJAZCVMOXQRK-UHFFFAOYSA-N ethenyl 7,7-dimethyloctanoate Chemical compound CC(C)(C)CCCCCC(=O)OC=C TVFJAZCVMOXQRK-UHFFFAOYSA-N 0.000 description 1
UIWXSTHGICQLQT-UHFFFAOYSA-N ethenyl propanoate Chemical compound CCC(=O)OC=C UIWXSTHGICQLQT-UHFFFAOYSA-N 0.000 description 1
150000002170 ethers Chemical class 0.000 description 1
238000002474 experimental method Methods 0.000 description 1
229930195729 fatty acid Natural products 0.000 description 1
239000000194 fatty acid Substances 0.000 description 1
150000004665 fatty acids Chemical class 0.000 description 1
229960003580 felodipine Drugs 0.000 description 1
229960002602 fendiline Drugs 0.000 description 1
SMANXXCATUTDDT-QPJJXVBHSA-N flunarizine Chemical compound C1=CC(F)=CC=C1C(C=1C=CC(F)=CC=1)N1CCN(C\C=C\C=2C=CC=CC=2)CC1 SMANXXCATUTDDT-QPJJXVBHSA-N 0.000 description 1
229960000326 flunarizine Drugs 0.000 description 1
229960002490 fosinopril Drugs 0.000 description 1
239000003205 fragrance Substances 0.000 description 1
208000024386 fungal infectious disease Diseases 0.000 description 1
239000001087 glyceryl triacetate Substances 0.000 description 1
235000013773 glyceryl triacetate Nutrition 0.000 description 1
150000008282 halocarbons Chemical class 0.000 description 1
229910052736 halogen Inorganic materials 0.000 description 1
125000005843 halogen group Chemical group 0.000 description 1
230000035876 healing Effects 0.000 description 1
230000036072 healthy nails Effects 0.000 description 1
125000004634 hexahydroazepinyl group Chemical group N1(CCCCCC1)* 0.000 description 1
FUZZWVXGSFPDMH-UHFFFAOYSA-N hexanoic acid Chemical compound CCCCCC(O)=O FUZZWVXGSFPDMH-UHFFFAOYSA-N 0.000 description 1
150000004679 hydroxides Chemical class 0.000 description 1
230000006872 improvement Effects 0.000 description 1
239000004615 ingredient Substances 0.000 description 1
208000014674 injury Diseases 0.000 description 1
229960004427 isradipine Drugs 0.000 description 1
230000001530 keratinolytic effect Effects 0.000 description 1
150000002576 ketones Chemical class 0.000 description 1
229940039717 lanolin Drugs 0.000 description 1
235000019388 lanolin Nutrition 0.000 description 1
229960002394 lisinopril Drugs 0.000 description 1
RLAWWYSOJDYHDC-BZSNNMDCSA-N lisinopril Chemical compound C([C@H](N[C@@H](CCCCN)C(=O)N1[C@@H](CCC1)C(O)=O)C(O)=O)CC1=CC=CC=C1 RLAWWYSOJDYHDC-BZSNNMDCSA-N 0.000 description 1
FPYJFEHAWHCUMM-UHFFFAOYSA-N maleic anhydride Chemical compound O=C1OC(=O)C=C1 FPYJFEHAWHCUMM-UHFFFAOYSA-N 0.000 description 1
VKQFCGNPDRICFG-UHFFFAOYSA-N methyl 2-methylpropyl 2,6-dimethyl-4-(2-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate Chemical compound COC(=O)C1=C(C)NC(C)=C(C(=O)OCC(C)C)C1C1=CC=CC=C1[N+]([O-])=O VKQFCGNPDRICFG-UHFFFAOYSA-N 0.000 description 1
125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
230000000813 microbial effect Effects 0.000 description 1
125000002757 morpholinyl group Chemical group 0.000 description 1
208000026721 nail disease Diseases 0.000 description 1
229960001783 nicardipine Drugs 0.000 description 1
HYIMSNHJOBLJNT-UHFFFAOYSA-N nifedipine Chemical compound COC(=O)C1=C(C)NC(C)=C(C(=O)OC)C1C1=CC=CC=C1[N+]([O-])=O HYIMSNHJOBLJNT-UHFFFAOYSA-N 0.000 description 1
229960001597 nifedipine Drugs 0.000 description 1
229960005366 nilvadipine Drugs 0.000 description 1
229960000715 nimodipine Drugs 0.000 description 1
229960000227 nisoldipine Drugs 0.000 description 1
229960005425 nitrendipine Drugs 0.000 description 1
DXGLGDHPHMLXJC-UHFFFAOYSA-N oxybenzone Chemical compound OC1=CC(OC)=CC=C1C(=O)C1=CC=CC=C1 DXGLGDHPHMLXJC-UHFFFAOYSA-N 0.000 description 1
FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Chemical class OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
244000052769 pathogen Species 0.000 description 1
230000000149 penetrating effect Effects 0.000 description 1
229960001476 pentoxifylline Drugs 0.000 description 1
230000008447 perception Effects 0.000 description 1
230000035699 permeability Effects 0.000 description 1
230000003711 photoprotective effect Effects 0.000 description 1
125000005498 phthalate group Chemical class 0.000 description 1
230000000704 physical effect Effects 0.000 description 1
230000009894 physiological stress Effects 0.000 description 1
125000004482 piperidin-4-yl group Chemical group N1CCC(CC1)* 0.000 description 1
229920000191 poly(N-vinyl pyrrolidone) Polymers 0.000 description 1
229920001296 polysiloxane Polymers 0.000 description 1
230000002265 prevention Effects 0.000 description 1
229960002934 propentofylline Drugs 0.000 description 1
230000001681 protective effect Effects 0.000 description 1
UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 1
ILVXOBCQQYKLDS-UHFFFAOYSA-N pyridine N-oxide Chemical class [O-][N+]1=CC=CC=C1 ILVXOBCQQYKLDS-UHFFFAOYSA-N 0.000 description 1
DOYOPBSXEIZLRE-UHFFFAOYSA-N pyrrole-3-carboxylic acid Natural products OC(=O)C=1C=CNC=1 DOYOPBSXEIZLRE-UHFFFAOYSA-N 0.000 description 1
229960001455 quinapril Drugs 0.000 description 1
JSDRRTOADPPCHY-HSQYWUDLSA-N quinapril Chemical compound C([C@@H](C(=O)OCC)N[C@@H](C)C(=O)N1[C@@H](CC2=CC=CC=C2C1)C(O)=O)CC1=CC=CC=C1 JSDRRTOADPPCHY-HSQYWUDLSA-N 0.000 description 1
230000008929 regeneration Effects 0.000 description 1
238000011069 regeneration method Methods 0.000 description 1
229920005989 resin Polymers 0.000 description 1
239000011347 resin Substances 0.000 description 1
239000003340 retarding agent Substances 0.000 description 1
229960004889 salicylic acid Drugs 0.000 description 1
150000004760 silicates Chemical class 0.000 description 1
239000007787 solid Substances 0.000 description 1
239000011877 solvent mixture Substances 0.000 description 1
230000007480 spreading Effects 0.000 description 1
229940124530 sulfonamide Drugs 0.000 description 1
150000003456 sulfonamides Chemical class 0.000 description 1
229920006027 ternary co-polymer Polymers 0.000 description 1
230000001225 therapeutic effect Effects 0.000 description 1
230000000699 topical effect Effects 0.000 description 1
231100000167 toxic agent Toxicity 0.000 description 1
230000002588 toxic effect Effects 0.000 description 1
229960002051 trandolapril Drugs 0.000 description 1
230000008733 trauma Effects 0.000 description 1
229960002622 triacetin Drugs 0.000 description 1
229940045136 urea Drugs 0.000 description 1
229960001722 verapamil Drugs 0.000 description 1
229960000881 verapamil hydrochloride Drugs 0.000 description 1
229920001567 vinyl ester resin Polymers 0.000 description 1
229920002554 vinyl polymer Polymers 0.000 description 1
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
230000003442 weekly effect Effects 0.000 description 1
239000000080 wetting agent Substances 0.000 description 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
- A61K8/4953—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom containing pyrimidine ring derivatives, e.g. minoxidil
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q3/00—Manicure or pedicure preparations
- A61Q3/02—Nail coatings

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Epidemiology (AREA)
Birds (AREA)
Dermatology (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Cosmetics (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicines Containing Plant Substances (AREA)
Finger-Pressure Massage (AREA)

JP52809597A 1996-02-06 1997-01-23 爪の成長促進剤 Expired - Lifetime JP4119480B2 (ja)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
DE19604190A DE19604190A1 (de)	1996-02-06	1996-02-06	Nagelwachstumsfördernde Zubereitungen
DE19604190.2		1996-02-06
PCT/EP1997/000311 WO1997028790A1 (de)	1996-02-06	1997-01-23	Nagelwachstumsfördernde zubereitungen

Publications (3)

Publication Number	Publication Date
JP2000504674A JP2000504674A (ja)	2000-04-18
JP2000504674A5 JP2000504674A5 (2)	2004-11-11
JP4119480B2 true JP4119480B2 (ja)	2008-07-16

Family

ID=7784609

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
JP52809597A Expired - Lifetime JP4119480B2 (ja)	1996-02-06	1997-01-23	爪の成長促進剤

Country Status (28)

Country	Link
US (1)	US6007798A (2)
EP (1)	EP0879052B1 (2)
JP (1)	JP4119480B2 (2)
KR (1)	KR100457849B1 (2)
CN (1)	CN1239157C (2)
AT (1)	ATE198155T1 (2)
AU (1)	AU706531B2 (2)
BG (1)	BG63485B1 (2)
BR (1)	BR9707353A (2)
CA (1)	CA2245693C (2)
CZ (1)	CZ290231B6 (2)
DE (2)	DE19604190A1 (2)
DK (1)	DK0879052T3 (2)
ES (1)	ES2154021T3 (2)
GR (1)	GR3035085T3 (2)
HU (1)	HU228521B1 (2)
IL (2)	IL125536A0 (2)
NO (1)	NO320443B1 (2)
NZ (1)	NZ326362A (2)
OA (1)	OA10829A (2)
PL (1)	PL186876B1 (2)
PT (1)	PT879052E (2)
RU (1)	RU2178289C2 (2)
TR (1)	TR199801475T2 (2)
TW (1)	TW493989B (2)
UA (1)	UA57015C2 (2)
WO (1)	WO1997028790A1 (2)
ZA (1)	ZA97930B (2)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6231875B1 (en) *	1998-03-31	2001-05-15	Johnson & Johnson Consumer Companies, Inc.	Acidified composition for topical treatment of nail and skin conditions
US6143794A (en) *	1998-04-17	2000-11-07	Bertek Pharmaceuticals, Inc.	Topical formulations for the treatment of nail fungal diseases
DE10011081A1 (de) *	2000-03-09	2001-09-13	Aventis Pharma Gmbh	Antiinfektive Wirkstoffkombinationen und ihre Verwendung zur topischen Behandlung von Pilzerkrankungen der Fuß- und Fingernägel
US8257688B2 (en) *	2000-03-27	2012-09-04	Taro Pharmaceuticals Industries	Controlled delivery system of antifungal and keratolytic agents for local treatment of fungal infections of the nail and surrounding tissues
US7074392B1 (en) *	2000-03-27	2006-07-11	Taro Pharmaceutical Industries Limited	Controllled delivery system of antifungal and keratolytic agents for local treatment of fungal infections
RU2207124C1 (ru) *	2002-04-24	2003-06-27	Закрытое акционерное общество "Брынцалов-А"	Крем "брамизил" противогрибкового действия
US20030049307A1 (en) *	2002-08-15	2003-03-13	Gyurik Robert J.	Pharmaceutical composition
RU2238092C2 (ru) *	2002-10-08	2004-10-20	Нестерук Владимир Викторович	Водная лекарственная композиция для лечения заболеваний кожи
US20040147534A1 (en) *	2003-01-23	2004-07-29	Foote Mary Ann	Topical composition and method for treating occlusive wounds
US20090143458A1 (en) *	2004-01-30	2009-06-04	Ace Aps	Use of ace inhibitors and/or angiostensin ii receptor antagonists for the improving and/or maintaining the skin tone and for the treatment of skin ageing
FR2871692B1 (fr) *	2004-06-22	2007-08-03	Epitact Md Sa	Procede et dispositif pour accelerer la croissance des phaneres, notamment des ongles
WO2006018024A2 (en) *	2004-08-18	2006-02-23	Ace Aps	Cosmetic and pharmaceutical compositions comprising ace inhibitors and/or angiotensin ii receptor antagonists
US7531058B2 (en) *	2005-02-24	2009-05-12	The Boeing Company	Reinforced rampdown for composite structural member and method for same
US20060251593A1 (en) *	2005-04-07	2006-11-09	Work By Docs, Inc.	Colored nail enamel treatment
US20080153122A1 (en) *	2006-12-21	2008-06-26	Susan Beth Cantor	Method and system for enhancing self-treatment of onychomycosis
RU2334504C1 (ru) *	2007-03-01	2008-09-27	Татьяна Вячеславовна Попкова	Средство для ухода за ногтями и способ его использования
US8470802B2 (en)	2008-10-08	2013-06-25	Conopco, Inc.	Sensory modifier
US8865678B2 (en)	2008-10-08	2014-10-21	Conopco, Inc.	Universal sensory structurant
KR20180084153A (ko) *	2011-06-10	2018-07-24	메르크 파텐트 게엠베하	Btk 억제 활성을 갖는 피리미딘 및 피리딘 화합물의 조성물 및 제조방법
WO2013052380A2 (en) *	2011-10-05	2013-04-11	Allergan, Inc.	Compositions for enhancing nail health
US8697753B1 (en)	2013-02-07	2014-04-15	Polichem Sa	Method of treating onychomycosis
RU2601896C2 (ru) *	2013-04-30	2016-11-10	Закрытое Акционерное Общество "Вертекс"	Комбинированный препарат для лечения грибковых заболеваний ногтей

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU599064B2 (en) *	1985-11-04	1990-07-12	Dermatological Products Of Texas	Film-forming, pharmaceutical vehicles for application of medicaments to nails, pharmaceutical compositions based on those vehicles, and methods of using same
DE3544983A1 (de) *	1985-12-19	1987-06-25	Hoechst Ag	Antimykotisch wirksamer nagellack
US4950475A (en) *	1988-07-19	1990-08-21	Imaginative Research Associates, Inc.	Novel film-forming gels with high concentrations of humectants and emollients
US4927626A (en) *	1988-10-28	1990-05-22	Devillez Richard L	Method for enhancement of unguis growth
FR2689008A1 (fr) *	1992-03-31	1993-10-01	Louis Benelli	Compositions efficaces notamment contre la chute des cheveux et pour favoriser leur régénération ainsi que celle des ongles.
GB9404293D0 (en) *	1994-03-04	1994-04-20	Shuster Sam	Drug delivery system

1996
- 1996-02-06 DE DE19604190A patent/DE19604190A1/de not_active Withdrawn
1997
- 1997-01-23 BR BR9707353A patent/BR9707353A/pt active IP Right Grant
- 1997-01-23 US US08/930,562 patent/US6007798A/en not_active Expired - Lifetime
- 1997-01-23 IL IL12553697A patent/IL125536A0/xx unknown
- 1997-01-23 ES ES97901078T patent/ES2154021T3/es not_active Expired - Lifetime
- 1997-01-23 JP JP52809597A patent/JP4119480B2/ja not_active Expired - Lifetime
- 1997-01-23 DK DK97901078T patent/DK0879052T3/da active
- 1997-01-23 NZ NZ326362A patent/NZ326362A/xx not_active IP Right Cessation
- 1997-01-23 TR TR1998/01475T patent/TR199801475T2/xx unknown
- 1997-01-23 EP EP97901078A patent/EP0879052B1/de not_active Expired - Lifetime
- 1997-01-23 AT AT97901078T patent/ATE198155T1/de active
- 1997-01-23 WO PCT/EP1997/000311 patent/WO1997028790A1/de not_active Ceased
- 1997-01-23 UA UA98094694A patent/UA57015C2/uk unknown
- 1997-01-23 CN CNB971920826A patent/CN1239157C/zh not_active Expired - Lifetime
- 1997-01-23 RU RU98116789/14A patent/RU2178289C2/ru active
- 1997-01-23 CA CA002245693A patent/CA2245693C/en not_active Expired - Lifetime
- 1997-01-23 PT PT97901078T patent/PT879052E/pt unknown
- 1997-01-23 DE DE59702786T patent/DE59702786D1/de not_active Expired - Lifetime
- 1997-01-23 CZ CZ19982439A patent/CZ290231B6/cs not_active IP Right Cessation
- 1997-01-23 KR KR10-1998-0706023A patent/KR100457849B1/ko not_active Expired - Lifetime
- 1997-01-23 PL PL97328397A patent/PL186876B1/pl unknown
- 1997-01-23 HU HU9900654A patent/HU228521B1/hu unknown
- 1997-01-23 AU AU14447/97A patent/AU706531B2/en not_active Expired
- 1997-02-04 TW TW086101258A patent/TW493989B/zh not_active IP Right Cessation
- 1997-02-05 ZA ZA9700930A patent/ZA97930B/xx unknown
1998
- 1998-07-15 BG BG102636A patent/BG63485B1/bg unknown
- 1998-07-27 IL IL12553698A patent/IL125536A/en not_active IP Right Cessation
- 1998-08-05 NO NO19983598A patent/NO320443B1/no not_active IP Right Cessation
- 1998-08-06 OA OA9800134A patent/OA10829A/fr unknown
2000
- 2000-12-15 GR GR20000402773T patent/GR3035085T3/el unknown

Also Published As

Publication number	Publication date
EP0879052A1 (de)	1998-11-25
BG102636A (en)	1999-02-26
CN1239157C (zh)	2006-02-01
CZ290231B6 (cs)	2002-06-12
AU1444797A (en)	1997-08-28
PL328397A1 (en)	1999-01-18
EP0879052B1 (de)	2000-12-20
HU228521B1 (en)	2013-03-28
US6007798A (en)	1999-12-28
NO983598D0 (no)	1998-08-05
TW493989B (en)	2002-07-11
CA2245693C (en)	2004-11-02
NZ326362A (en)	1999-01-28
CN1210460A (zh)	1999-03-10
JP2000504674A (ja)	2000-04-18
DK0879052T3 (da)	2001-02-19
HUP9900654A3 (en)	2001-11-28
ZA97930B (en)	1997-08-06
TR199801475T2 (xx)	1998-10-21
ATE198155T1 (de)	2001-01-15
DE19604190A1 (de)	1997-08-07
IL125536A (en)	2001-10-31
HK1018398A1 (en)	1999-12-24
PT879052E (pt)	2001-04-30
KR100457849B1 (ko)	2005-07-08
OA10829A (fr)	2003-01-29
CA2245693A1 (en)	1997-08-14
UA57015C2 (uk)	2003-06-16
BG63485B1 (bg)	2002-03-29
DE59702786D1 (de)	2001-01-25
NO320443B1 (no)	2005-12-05
GR3035085T3 (en)	2001-03-30
IL125536A0 (en)	1999-03-12
ES2154021T3 (es)	2001-03-16
WO1997028790A1 (de)	1997-08-14
KR19990082294A (ko)	1999-11-25
PL186876B1 (pl)	2004-03-31
RU2178289C2 (ru)	2002-01-20
AU706531B2 (en)	1999-06-17
BR9707353A (pt)	1999-07-20
NO983598L (no)	1998-10-02
CZ243998A3 (cs)	1998-11-11
HUP9900654A1 (hu)	1999-07-28

Legal Events

Date	Code	Title	Description
2004-02-12	A521	Request for written amendment filed	Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20040121
2004-02-12	A621	Written request for application examination	Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20040121
2005-10-20	A72	Notification of change in name of applicant	Free format text: JAPANESE INTERMEDIATE CODE: A721 Effective date: 20050930
2007-11-13	A131	Notification of reasons for refusal	Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20071113
2008-03-06	A521	Request for written amendment filed	Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20080213
2008-03-25	TRDD	Decision of grant or rejection written
2008-04-01	A01	Written decision to grant a patent or to grant a registration (utility model)	Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20080401
2008-05-01	A61	First payment of annual fees (during grant procedure)	Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20080425
2008-05-02	R150	Certificate of patent or registration of utility model	Free format text: JAPANESE INTERMEDIATE CODE: R150
2008-05-08	FPAY	Renewal fee payment (event date is renewal date of database)	Free format text: PAYMENT UNTIL: 20110502 Year of fee payment: 3
2011-04-28	FPAY	Renewal fee payment (event date is renewal date of database)	Free format text: PAYMENT UNTIL: 20110502 Year of fee payment: 3
2011-05-10	FPAY	Renewal fee payment (event date is renewal date of database)	Free format text: PAYMENT UNTIL: 20120502 Year of fee payment: 4
2012-05-15	FPAY	Renewal fee payment (event date is renewal date of database)	Free format text: PAYMENT UNTIL: 20130502 Year of fee payment: 5
2013-05-14	R250	Receipt of annual fees	Free format text: JAPANESE INTERMEDIATE CODE: R250
2014-05-07	R250	Receipt of annual fees	Free format text: JAPANESE INTERMEDIATE CODE: R250
2015-05-12	R250	Receipt of annual fees	Free format text: JAPANESE INTERMEDIATE CODE: R250
2016-05-10	R250	Receipt of annual fees	Free format text: JAPANESE INTERMEDIATE CODE: R250
2017-01-23	EXPY	Cancellation because of completion of term

Publication	Publication Date	Title
JP4119480B2 (ja)	2008-07-16	爪の成長促進剤
Olsen et al.	1985	Topical minoxidil in early male pattern baldness
JP7765461B2 (ja)	2025-11-06	脱毛防止または発毛促進用の組成物
US20030012749A1 (en)	2003-01-16	Preparations for the non-traumatic excision of a nail
JP3653098B2 (ja)	2005-05-25	爪真菌症治療用のグリセリルトリアセテートの使用
JP5162064B2 (ja)	2013-03-13	抗アンドロゲン作用を有する物質を局所適用するための処方物
ES2242027T3 (es)	2005-11-01	Preparacion para eleminar material queratinoso anormal.
JP2693535B2 (ja)	1997-12-24	ピリミジン誘導体および非ステロイド抗炎症剤の組み合わせからなる頭皮外用剤
JP2003530420A (ja)	2003-10-14	ケラチン物質の化粧処置におけるアルコールデヒドロゲナーゼ阻害剤の使用
KR20160123549A (ko)	2016-10-26	모발 강화용 화장료 조성물
HK1256597A1 (zh)	2019-09-27	含有细胞老化抑制剂作为有效成分的皮肤皱纹改善用及皮肤损伤炎症疾病治疗用组合物
US6713050B2 (en)	2004-03-30	Method and composition for rejuvenating hairs, nails, tissues, cells and organs by ex-vivo or immersive treatment
HK1018398B (en)	2006-07-07	Nail frowth-promoting formulations
CN116115600A (zh)	2023-05-16	依普黄酮在制备防脱发、生发药物中的用途
CN121714464A (zh)	2026-03-24	促进生发用或防脱发用组合物
JPS60208907A (ja)	1985-10-21	毛髪成長刺激剤
JPS6322511A (ja)	1988-01-30	ピペリジノピリミジン誘導体を基剤とする毛髪の成長を誘発及び刺激し且つ毛髪の減損を減少させる組成物
EP0333743A1 (en)	1989-09-27	Use of nicorandil to treat alopecia